Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Result of AGM

12 May 2021 12:37

RNS Number : 4110Y
Maven Income & Growth VCT 4 PLC
12 May 2021
 

Maven Income and Growth VCT 4 PLC (the Company) - Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 12 noon at the offices of Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow G2 2LW on Wednesday 12 May 2021, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 10 May 2021, the total number of voting rights in the Company stood at 111,523,142 Ordinary Shares. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 8,025,919 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

7,896,641

99,532

10,337

19,409

8,025,919

2

To approve the Directors' Remuneration Report.

6,817,658

125,965

933,552

148,744

8,025,919

3

To approve the final dividend.

 

7,904,206

102,304

3,075

16,334

8,025,919

4

To re-elect Mr Linthwaite as a Director.

 

6,875,217

170,920

135,964

843,818

8,025,919

5

To re-elect Mr Graham-Wood as a Director.

6,899,247

170,920

125,516

830,236

8,025,919

6

To re-elect Mr Scott as a Director.

 

6,885,115

170,920

139,648

830,236

8,025,919

7

To re-elect Mr Nixon as a Director.

 

6,837,253

170,920

163,153

854,593

8,025,919

8

To re-elect Mr Gray as a Director.

 

7,014,493

156,808

22,927

831,691

8,025,919

9

To re-appoint Deloitte LLP as Auditor.

 

6,728,964

140,014

1,058,111

98,830

8,025,919

10

To authorise the Directors to fix the remuneration of the Auditor.

7,820,420

141,429

41,060

23,010

8,025,919

11

To authorise the Directors to allot new shares.

7,024,304

132,727

846,787

22,101

8,025,919

12

To authorise disapplication of pre-emption rights.

6,709,973

133,586

1,132,238

50,122

8,025,919

13

To authorise the Company to purchase its own shares.

6,476,416

332,209

1,195,541

21,753

8,025,919

14

To allow a General Meeting to be called on not less than 14 days' notice.

7,573,611

149,981

271,768

30,559

8,025,919

 

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

12 May 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBBGDULXBDGBD
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.